Hepatobiliary & Pancreatic Diseases International

Scope & Guideline

Advancing knowledge in hepatobiliary and pancreatic health.

Introduction

Delve into the academic richness of Hepatobiliary & Pancreatic Diseases International with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1499-3872
PublisherELSEVIER
Support Open AccessNo
CountrySingapore
TypeJournal
Convergefrom 2002 to 2024
AbbreviationHEPATOB PANCREAT DIS / Hepatob. Pancreatic. Dis. Int.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Hepatobiliary & Pancreatic Diseases International' focuses on advancing knowledge in the fields of hepatology, biliary diseases, and pancreatic disorders. It aims to provide a platform for high-quality research that contributes to clinical practice and improves patient outcomes in these areas.
  1. Liver Diseases and Transplantation:
    The journal emphasizes research on various liver diseases, including hepatocellular carcinoma, liver cirrhosis, and liver transplantation techniques. It aims to improve understanding of disease mechanisms and enhance surgical and therapeutic approaches.
  2. Pancreatic Disorders:
    There is a significant focus on pancreatic diseases, particularly pancreatic cancer and pancreatitis. The journal publishes studies on diagnosis, treatment strategies, and novel surgical techniques related to these conditions.
  3. Biliary Pathology:
    Research on biliary diseases, including cholangiocarcinoma and complications from biliary interventions, is a core area. The journal explores both surgical and non-surgical management options.
  4. Innovative Surgical Techniques:
    The journal highlights advancements in surgical methods, including minimally invasive techniques and robotic surgery, aimed at improving patient outcomes in liver and pancreatic surgeries.
  5. Clinical and Translational Research:
    Emphasizing the bridge between laboratory research and clinical application, the journal encourages studies that translate scientific findings into practical treatments for liver and pancreatic diseases.
  6. Immunotherapy and Molecular Approaches:
    There is a growing interest in the role of immunotherapy and molecular biology in the treatment of hepatobiliary and pancreatic cancers, reflecting modern therapeutic strategies.
The journal has identified several emerging themes that reflect the latest advancements and interests in the fields of hepatology and pancreatic diseases. These trends are indicative of the evolving landscape of research and clinical practice.
  1. Personalized Medicine and Genomics:
    There is an increasing focus on personalized medicine approaches, including genomic profiling and tailored therapies for hepatobiliary and pancreatic cancers, reflecting the trend towards individualized patient care.
  2. Immunotherapy Advances:
    Research on immunotherapy, including checkpoint inhibitors and novel immunotherapeutic strategies, has gained significant traction, highlighting its potential in treating liver and pancreatic cancers.
  3. Artificial Intelligence and Machine Learning:
    The application of AI and machine learning for diagnostics and treatment predictions is on the rise, showcasing innovations in data-driven approaches to hepatobiliary and pancreatic diseases.
  4. Multidisciplinary Approaches to Treatment:
    Emerging themes include collaborative, multidisciplinary approaches to managing complex cases in hepatobiliary and pancreatic surgery, integrating surgical, medical, and supportive care.
  5. Microbiome and Liver Health:
    Research exploring the relationship between the gut microbiome and liver disease is gaining attention, indicating a growing interest in the microbiome's role in health and disease.
  6. Regenerative Medicine and Stem Cell Therapy:
    There is an increasing exploration of regenerative medicine and stem cell therapy as potential treatments for liver diseases, reflecting advancements in biological therapies.

Declining or Waning

While the journal continues to explore a broad range of topics, certain areas of research have shown a decline in focus over recent years. This may reflect shifts in clinical priorities or advancements in treatment methodologies that have rendered some topics less relevant.
  1. Traditional Surgical Techniques:
    There appears to be a waning emphasis on traditional open surgical techniques for hepatobiliary and pancreatic surgeries, as the field increasingly adopts minimally invasive and robotic approaches.
  2. Conventional Imaging Techniques:
    With the advent of advanced imaging modalities and radiomics, traditional imaging methods for diagnosing liver and pancreatic diseases are becoming less prominent in the journal's publications.
  3. Single-Agent Chemotherapies:
    Research focused solely on single-agent chemotherapy regimens for hepatobiliary malignancies has decreased, likely due to the shift towards combination therapies and personalized medicine.
  4. Basic Science Studies:
    There is a noticeable decline in basic science studies that do not directly translate to clinical practice, as the journal prioritizes research with immediate clinical applicability.
  5. Epidemiological Studies without Novel Insights:
    Epidemiological studies that do not provide new insights or advancements in understanding disease mechanisms or treatment are becoming less frequent.

Similar Journals

Frontline Gastroenterology

Championing Excellence in Gastroenterological Research
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

Journal of Hepato-Biliary-Pancreatic Sciences

Innovating practices in hepatobiliary and pancreatic disorders.
Publisher: WILEYISSN: 1868-6974Frequency: 6 issues/year

The Journal of Hepato-Biliary-Pancreatic Sciences, published by WILEY, is a premier academic platform dedicated to advancing research in the domains of hepatology and surgical sciences. With an impressive impact factor and categorized as Q2 in Hepatology and Q1 in Surgery for 2023, the journal ranks #85 out of 495 in Medicine Surgery and #36 out of 70 in Medicine Hepatology, highlighting its significant contributions to the medical community. Although the journal's coverage in Scopus was discontinued from 2010 to 2021, its previous engagement with the Scopus database reinforces its relevance and quality control within the field. Researchers, clinicians, and students will find a wealth of rigorously peer-reviewed articles that address critical issues and innovative practices in the treatment of hepatobiliary and pancreatic disorders. As an essential resource for advancing knowledge and enhancing clinical practice, the Journal of Hepato-Biliary-Pancreatic Sciences aims to foster significant dialogue and collaboration among professionals dedicated to improving patient outcomes in these intertwining specialties.

Canadian Journal of Gastroenterology and Hepatology

Elevating Standards in Gastroenterology and Hepatology Research
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

Expert Review of Gastroenterology & Hepatology

Exploring the Frontiers of Digestive Health
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-4124Frequency: 8 issues/year

Expert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.

Gastroenterologia y Hepatologia

Pioneering research for better digestive disease outcomes.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Transforming gastroenterology with cutting-edge research.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

JGH Open

Unlocking Insights in Gastrointestinal Health
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

HEPATOLOGY

Pioneering innovative solutions for liver health challenges.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0270-9139Frequency: 12 issues/year

HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.

JHEP Reports

Driving excellence in gastroenterology and internal medicine.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.

Gut and Liver

Empowering researchers with open access to critical findings.
Publisher: EDITORIAL OFFICE GUT & LIVERISSN: 1976-2283Frequency: 6 issues/year

Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.